Nateglinide
Class
Hypoglycemic agents
Subclass
Glinides
Substance name
Nateglinide
Common formulations
Tablet
Dosage and administration
Adults patients
No dosages available
Indications for use
Labeled indications
Adults
Safety risks
Contraindications
T1DM or diabetic ketoacidosis
Pre-existing hypoglycemia
Specific populations
Renal impairment
eGFR 30-50 mL/min/1.73 m²
eGFR 15-30 mL/min/1.73 m²
eGFR < 15 mL/min/1.73 m²
Renal replacement therapy
Continuous renal replacement
Intermittent hemodialysis
Peritoneal dialysis
Hepatic impairment
Child-Pugh A (mild)
Child-Pugh B (moderate)
Child-Pugh C (severe)
Pregnancy and breastfeeding
Pregnancy
All trimesters • Australia Category: C
Breastfeeding
Consider alternative agents that may be safer.
Unknown amount excreted in breastmilk.
Unknown drug levels in breastfed infants.
Adverse reactions
Common 1-10%
Unknown frequency
Interactions
Drug(s)
Check Interactions
Reset
What did you think about this content?
Sign up for free to access the full drug resource